The genetic engineering industry in Latin America is rapidly evolving, driven by advancements in biotechnology and genomics. This sector is characterized by a range of businesses, from startups focused on gene therapy to established firms working on agricultural genetic improvements. Companies operate in several fields including healthcare, agriculture, and industrial biotech, all aiming for innovative solutions to pressing challenges. With increasing investments and supportive policies, the industry is set for substantial growth, fostering better healthcare outcomes and sustainable agricultural practices. Furthermore, engaging academic institutions has propelled research, enhancing commercialization opportunities.

This list highlights prominent investors in the Latin American genetic engineering sector. The investors exhibit a mix of venture capital firms and corporate entities, headquartered primarily in Brazil and Argentina. Founded between 2008 and 2021, they vary in size but most are small to medium-sized firms with focused investment strategies. In 2024, these investors collectively engaged in numerous transactions, showcasing their commitment to financing emerging biotech companies that are innovating in fields such as gene therapy and agricultural biotechnology.

Top 18 Genetic Engineering Investors in Latin America

1. bossa invest

• Website: bossainvest.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn: bossainvest

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly within the technology sector. Bossa Invest provides capital, strategic guidance, and access to a network of co-investors, aiming to empower entrepreneurs and foster growth in the startup ecosystem. Among their notable transactions, Bossa Invest has invested in Caribou Biosciences, which focuses on CRISPR technology for oncology therapies, and Excision BioTherapeutics, which is advancing gene therapies for chronic HIV infection. These investments demonstrate Bossa Invest's active role in the genetic engineering field, supporting companies that are at the forefront of biotechnological advancements.

2. Eretz.bio

• Website: eretz.bio
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn: eretz.bio

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with the Hospital Israelita Albert Einstein, focusing on incubating startups in the healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. In 2024, Eretz.bio was involved in several funding rounds, including Speratum Biopharma, which raised funds in a venture round, and multiple seed rounds for companies like RadBio and Oncobiomed. These transactions highlight Eretz.bio's active role in supporting biotechnology startups, which often intersect with genetic engineering, making them a relevant player in this field.

3. GRIDS Capital

• Website: gridscapital.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn: grids-capital

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures, providing investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Among their notable transactions, they invested in Immusoft, a biotech startup focused on gene therapy technology, and BigHat Biosciences, which raised $75 million in a Series B funding round to advance its biotechnology initiatives. These investments highlight GRIDS Capital's active role in the genetic engineering space, particularly in supporting companies that are developing cutting-edge therapeutic solutions.

4. The Ganesha Lab

• Website: theganeshalab.com
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn: ganeshalab

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through programs like BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate the complexities of the biotech industry and scale their innovations for global impact. Notably, they have been involved in transactions such as Botanical Solutions, which raised $3,300,000 in a Seed Round in December 2020, indicating their active role in funding biotech initiatives. They also supported Smart Tissues in a Pre-Seed Round in January 2020, further demonstrating their commitment to nurturing biotech innovations. Their recent transactions, including non-equity assistance for Nanotransfer and Amplify Dynamics, reflect their ongoing engagement in the biotech sector, which may include genetic engineering applications.

5. AIR Capital

• Website: aircapital.vc
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn: air-capital-vc

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm focuses on early-stage startups that are pioneering disruptive innovations relevant for humanity. AIR Capital provides both investment and consulting services, leveraging their extensive experience in the technology sector. Their portfolio showcases a diverse range of startups across various industries, with a notable emphasis on biotechnology. Among their relevant transactions, AIR Capital invested in Aplife Biotech, which focuses on biotechnological advancements, and Ergo Bioscience, which is involved in bioscience innovations. These investments highlight AIR Capital's commitment to fostering innovation in the genetic engineering space, making them a significant player in this sector.

6. IKJ Capital

• Website: ikj.capital
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn: irukandji-capital

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in early-stage investments in healthcare technology companies, focusing on significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital has been active in the investment landscape, participating in several funding rounds. Notably, they invested in Shift Bioscience, which raised over $16 million in a seed round, indicating a commitment to innovative solutions in biotechnology and genetic engineering. Additionally, they have supported Portal in multiple funding rounds, raising a total of $12 million, and FidoCure, which focuses on veterinary health solutions, showcasing their diverse investment strategy within the healthcare sector. These transactions highlight IKJ Capital's role in fostering innovation in areas that intersect with genetic engineering.

7. Cites

• Website: cites-gss.com
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn: cites

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting the development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups aiming to transform innovative ideas into successful businesses. Notably, Cites has made significant investments in the biotechnology sector, including transactions such as Limay Biosciences, which raised $600,000 in August 2022, and Ergo Bioscience, which raised $1,602,220 in September 2023. These investments highlight Cites' commitment to fostering advancements in biotechnology, making them a relevant player in the genetic engineering landscape.

8. SP Ventures

• Website: spventures.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2007
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn: sp-ventures

SP Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The firm specializes in investments in technology-driven solutions for the agriculture and food sectors, particularly in Latin America. They support early-stage startups by providing capital and consulting services to help them innovate and grow. Among their notable transactions, SP Ventures has invested in Puna Bio, which raised funds to commercially launch its first soybean seed treatment and expand field trials for wheat and corn, indicating a focus on genetic engineering in agriculture. Additionally, their investment in Solubio Agricultural Technologies further emphasizes their commitment to advancing agricultural technologies, including those that may involve genetic engineering. Overall, SP Ventures is actively engaged in the AgFood value chain, making them a significant player in the genetic engineering investment landscape.

9. Zentynel Frontier Investments

• Website: zentynel.com
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn: zentynel-frontier-investments

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in the sector. In 2024, Zentynel was involved in several notable transactions, including a venture round for BIOMAKERS and a $2.5 million seed round for Xeptiva Therapeutics, which focuses on therapeutic solutions. A significant investment was made in Autem Therapeutics, where Zentynel led a $10 million Series A-1 financing round aimed at developing a novel bioelectric oncology treatment platform for solid tumor cancers. Additionally, they participated in a seed funding round for MultiplAI Health, a diagnostics company, which highlights their diverse investment strategy within the biotechnology landscape. Overall, Zentynel's focus on high-growth potential companies in biotechnology positions them as a relevant player in the genetic engineering investment space.

10. Kptl

• Website: kptl.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn: inseed-investimentos

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in the investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Among their notable transactions, KPTL has invested in companies such as BioClone, which is involved in biotechnology, and Omics Animal Biotechnology, which focuses on genetic engineering applications in animal science. Additionally, they have supported Akmey Biotecnologia Têxtil, a company that integrates biotechnology into textile production. These investments highlight KPTL's active role in the genetic engineering industry, providing capital and strategic guidance to help these companies grow and succeed in their respective markets.

11. The Yield Lab LATAM

• Website: theyieldlablatam.com
• Type: Venture Capital
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn: theyieldlablatam

The Yield Lab LATAM is a venture capital firm based in Buenos Aires, Argentina, founded in 2017. It specializes in the AgriFoodTech sector, investing in early-stage startups that tackle challenges within the agri-food industry. The firm provides comprehensive support programs, including governance, talent development, and fundraising assistance, while connecting innovative companies with investors across Latin America. Notably, The Yield Lab LATAM has been involved in transactions with companies like Botanical Solutions, which focuses on botanical-based products, and Symbiomics, which is engaged in biotechnology. These investments highlight their commitment to supporting advancements in agricultural biotechnology, including genetic engineering applications.

12. Draper Cygnus

• Website: drapercygnus.vc
• Type: Venture Capital
• Headquarters: Lomas Del Mirador, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn: drapercygnus

Draper Cygnus is a venture capital firm based in Lomas Del Mirador, Buenos Aires, Argentina, founded in 2017. The firm specializes in investing in deep-tech startups founded by Latino entrepreneurs, providing both funding and support to help these companies develop innovative technologies across various sectors, including AI, biotechnology, and space technology. In 2024, Draper Cygnus has already made four investments, including notable transactions such as Ayuvant, which raised an undisclosed amount in a Seed Round, and Calice, which secured $1.5 million in a Seed Round. These investments highlight their commitment to supporting biotechnology ventures, which are closely related to genetic engineering. Additionally, their previous investments in companies like ArgenTag and Panarum further demonstrate their active engagement in the biotechnology space.

13. DNA Capital

• Website: dnacapital.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: dna-capital-br

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, specializing in healthcare investments. Founded in 2013, the firm partners with healthcare businesses and startups, providing capital and strategic support to foster growth and innovation in the healthcare sector. DNA Capital has been involved in several notable transactions, including a $30 million Series A investment in Spotlight Therapeutics, which focuses on genetic therapies, and a $30 million Series C investment in Cambridge Epigenetix, a company that develops epigenetic technologies. These investments highlight DNA Capital's commitment to advancing genetic engineering and related healthcare innovations.

14. Fen Ventures

• Website: fenventures.com
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn: fen-ventures

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage investments within the Latin American tech sector, providing capital, strategic support, and networking opportunities to entrepreneurs. In 2024, Fen Ventures has been involved in several notable transactions in the biotechnology field, including a $2.5 million seed investment in Xeptiva Therapeutics, which focuses on therapeutic solutions. They also participated in a funding round for Bioeutectics, which is developing green solvents, and in Michroma, a company that has raised $6.4 million for its innovative biotechnological applications. These investments highlight Fen Ventures' commitment to fostering innovation in the biotech and genetic engineering sectors, aiming to support companies that are making significant advancements in these fields.

15. Clave Capital

• Website: clavecapital.com.br
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: clavecapital

Clave Capital is a venture capital firm based in Jardim Paulista, Sao Paulo, Brazil, founded in 2021. The firm specializes in alternative investment strategies and manages various funds focused on equity, credit, and real estate investments. Clave Capital has a commitment to excellence and disciplined capital allocation, catering to both businesses and individual investors. Notably, Clave Capital has participated in significant funding rounds within the genetic engineering context, including a €6.7 million investment in OneChain Immunotherapeutics, which is developing innovative CAR-T therapies. Additionally, they led a €5.4 million funding round for ADmit Therapeutics, which is working on solutions for Alzheimer's disease, and invested in MiMARK, a company focused on in vitro diagnostics for cancer. These transactions highlight Clave Capital's active role in supporting advancements in genetic engineering and related healthcare technologies.

16. Aurus

• Website: aurus.cl
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: aurus

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm specializes in partnering with entrepreneurs and startups, offering strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Notably, Aurus has been involved in multiple funding rounds for Andes Biotechnologies, a company engaged in the biotechnology sector. Their investments include a Series A round in 2010, followed by several venture rounds and a Series B round up until 2014. This consistent support for Andes Biotechnologies highlights Aurus's commitment to the biotechnology field, which is closely related to genetic engineering.

17. Innova Capital

• Website: innovacapital.com.br
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn: innova-capital---fip

Innova Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in technology companies across various sectors, with a particular focus on innovative and scalable businesses. Their investment portfolio includes companies in anti-fraud solutions, embedded finance, and online credit marketplaces, primarily serving clients in e-commerce and finance. Notably, Innova Capital participated in a Series B funding round for Editas Medicine, a prominent player in the genetic engineering field, specifically in CRISPR technology. This investment highlights their engagement with cutting-edge biotechnology and their commitment to supporting advancements in genetic engineering.

18. big_bets

• Website: bigbets.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is an investment and consulting agency based in Sao Paulo, Brazil, founded in 2019. They specialize in partnering with entrepreneurs to support the development of technology startups, providing investment consulting, mentoring, and strategic guidance to help early-stage companies navigate challenges and achieve growth. In 2023, big_bets participated in significant transactions in the biotechnology sector, including a seed round for Pepper Bio, a drug discovery startup that raised $6.5 million, and Menten AI, which raised an undisclosed amount. These investments highlight their engagement in the biotech and genetic engineering industries, showcasing their commitment to innovative technology startups.

Genetic Engineering Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
bossa invest	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
Eretz.bio	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
GRIDS Capital	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
The Ganesha Lab	Las Condes, Santiago, Chile	1-10	2016	5
AIR Capital	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
IKJ Capital	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
Cites	Sunchales, Santa Fe, Argentina	51-200	2014	2
SP Ventures	Sao Paulo, Sao Paulo, Brazil	1-10	2007	3
Zentynel Frontier Investments	Santiago, Santiago, Chile	1-10	2017	4
Kptl	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
The Yield Lab LATAM	Buenos Aires, Buenos Aires, Argentina	11-50	2017	5
Draper Cygnus	Lomas Del Mirador, Buenos Aires, Argentina	1-10	2017	4
DNA Capital	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
Fen Ventures	Las Condes, Santiago, Chile	1-10	2012	5
Clave Capital	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
Aurus	Lo Barnechea, Santiago, Chile	11-50	2008	1
Innova Capital	Sao Paulo, Sao Paulo, Brazil	1-10	2011	2
big_bets	Sao Paulo, Sao Paulo, Brazil	1-10	2019	10

Want to find more investors focusing on the genetic engineering industry?

If you want to find more investors that are active in the genetic engineeringindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and their sizes.
• Portfolio: Companies they've invested in.
• Contact data: Key dealmakers, including their emails and phonenumbers.
• ...and much more!